NIH Reporter #5R01CA272490-03

NCI Research Grant for Mitochondrial NAD+ in Acute Myeloid Leukemias

This opportunity is a research grant solicitation from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), focused on mitochondrial NAD+ in Acute Myeloid Leukemias. - Government Buyer: - National Cancer Institute (NCI), part of the NIH - Participating Organization: - University of Texas at Austin - Products/Services Requested: - Research on mitochondrial NAD+ in Acute Myeloid Leukemias - No specific products, part numbers, or quantities are listed - OEMs and Vendors: - No OEMs or commercial vendors are specified in the notice - Unique or Notable Requirements: - Research must address cancer, hematology, pediatric, or rare diseases - Open to eligible research institutions, particularly schools of medicine - Estimated grant value is approximately $522,539

Description

This is a grant opportunity from the NIH for research on mitochondrial NAD+ in Acute Myeloid Leukemia. The project is led by Xiaolu Ang Cambronne at the University of Texas at Austin. The award amount is approximately $522,539. The solicitation is open for applications with a response deadline of August 1, 2025.

View original listing